SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Core & Main, Inc. (CNM) trades at a trailing P/E of 21.9, forward P/E of 23.6. Trailing earnings yield is 4.57%, forward earnings yield 4.24%. PEG 2.57. Graham Number is $23.85.
Criteria proven by this page:
- VALUE (60/100, Pass) — P/E is below market average (21.9); analyst target implies upside (+18.7%); earnings yield beats bond yields (4.57%).
- PEG Ratio 2.57 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 4.57% — roughly competitive with bond yields (~4.3%), moderate risk-reward.
- Analyst consensus target $64.00 (+18.7% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 59/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
60/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CNM
Valuation Multiples
P/E (TTM)21.9
Forward P/E23.6
PEG Ratio2.57
Forward PEG1.47
P/B Ratio4.83
P/S Ratio1.25
EV/EBITDA12.9
Per Share Data
EPS (TTM)$2.32
Forward EPS (Est.)$2.29
Book Value / Share$10.90
Revenue / Share$40.20
FCF / Share$3.18
Yields & Fair Value
Earnings Yield4.57%
Forward Earnings Yield4.24%
Dividend Yield0.00%
Graham Number$23.85
SharesGrow IV$83.09 (+54%)
Analyst Target$64.00 (+18.7%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2019 |
87.5 |
0.00 |
0.00 |
1.00 |
0.79% |
| 2020 |
133.7 |
-3.84 |
7.50 |
1.42 |
6.71% |
| 2021 |
130.1 |
0.00 |
6.01 |
1.32 |
0.43% |
| 2022 |
23.1 |
0.05 |
2.89 |
0.77 |
- |
| 2023 |
9.9 |
0.04 |
2.08 |
0.55 |
- |
| 2024 |
19.6 |
-2.25 |
5.00 |
1.08 |
- |
| 2025 |
26.0 |
-1.07 |
6.30 |
1.44 |
- |
| 2026 |
23.6 |
2.80 |
5.20 |
1.36 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2018 |
$0.15 |
$3.2B |
$36.6M |
1.1% |
| 2019 |
$0.26 |
$3.39B |
$36M |
1.1% |
| 2020 |
$0.23 |
$3.64B |
$37M |
1% |
| 2021 |
$1.34 |
$5B |
$225M |
4.5% |
| 2022 |
$2.36 |
$6.65B |
$581M |
8.7% |
| 2023 |
$2.15 |
$6.7B |
$371M |
5.5% |
| 2024 |
$2.13 |
$7.44B |
$411M |
5.5% |
| 2025 |
$2.31 |
$7.65B |
$441M |
5.8% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$2.29 |
$2.28 – $2.29 |
$7.66B |
$7.52B – $7.67B |
4 |
| 2027 |
$2.54 |
$2.53 – $2.56 |
$7.89B |
$7.87B – $7.92B |
5 |
| 2028 |
$2.96 |
$2.95 – $2.98 |
$8.28B |
$8.18B – $8.35B |
5 |
| 2029 |
$3.62 |
$3.35 – $3.81 |
$8.69B |
$8.67B – $8.72B |
5 |
